Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic merkel cell carcinoma (mMCC) progressed on chemotherapy
Tom van Hagen, Shahneen Sandhu, Paul Nghiem, Shailender Bhatia, Andrew S. Brohl, Omid Hamid, Janice M. Mehnert, Patrick Terheyden, Kent C. Shih, Isaac Brownell, Célèste Lebbé, Karl D. Lewis, Gerald P. Linette, Michèle Milella, Meliessa Hennessy, Marcis Bajars, Christine Hicking, Sandra P. D’Angelo (2018). Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic merkel cell carcinoma (mMCC) progressed on chemotherapy. , 14
Article288 days agoTwo-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic merkel cell carcinoma (mMCC) progressed on chemotherapy
Tom van Hagen, Shahneen Sandhu, Paul Nghiem, Shailender Bhatia, Andrew S. Brohl, Omid Hamid, Janice M. Mehnert, Patrick Terheyden, Kent C. Shih, Isaac Brownell, Célèste Lebbé, Karl D. Lewis, Gerald P. Linette, Michèle Milella, Meliessa Hennessy, Marcis Bajars, Christine Hicking, Sandra P. D’Angelo (2018). Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic merkel cell carcinoma (mMCC) progressed on chemotherapy. , 14
Article288 days agoPerformance status and quality of life in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma receiving afamitresgene autoleucel
Michael J. Wagner, Colin Lunt, Dejka M. Araujo, Jean Yves Blay, Mihaela Druta, Steven Attia, Claudia Maria Valverde Morales, Kristen N. Ganjoo, Scott M. Schuetze, Sandra P. D’Angelo, Elizabeth T. Loggers, Albiruni Abdul Razak, Édouard Forcade, Sandra J. Strauss, Erin Van Winkle, Peter Bayer, Jane P. F. Bai, D. Bestul, Viral Desai, Murray Yule, Dennis Williams, Elliot Norry, Brian A. Van Tine (2025). Performance status and quality of life in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma receiving afamitresgene autoleucel. , 4, DOI: https://doi.org/10.1016/j.esmorc.2025.100025.
Article33 days agoLong-Term Survival of Patients with Advanced/Metastatic Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Who Received the T-Cell Receptor T-Cell Therapy, Afamitresgene Autoleucel, in the Phase 2 Spearhead-1 Trial
Sandra P. D’Angelo, Mihaela Druta, Brian A. Van Tine, Scott M. Schuetze, Jean Yves Blay, Claudia Maria Valverde Morales, Édouard Forcade, Kristen N. Ganjoo, Axel Le Cesne, Sandra J. Strauss, Dejka M. Araujo, Edwin Choy, Christopher D. Dupont, Dennis Williams, Jane P. F. Bai, Lilliam Fernandes, Erin Van Winkle, Amber K. O’Connor, Elliot Norry (2025). Long-Term Survival of Patients with Advanced/Metastatic Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Who Received the T-Cell Receptor T-Cell Therapy, Afamitresgene Autoleucel, in the Phase 2 Spearhead-1 Trial. , 31(2), DOI: https://doi.org/10.1016/j.jtct.2025.01.380.
Article33 days agoAfamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak, Mark Agulnik, Steven Attia, Jean Yves Blay, Irene Carrasco García, John A. Charlson, Edwin Choy, George D. Demetri, Mihaela Druta, Édouard Forcade, Kristen N. Ganjoo, John Glod, Vicki L. Keedy, Axel Le Cesne, David A. Liebner, Víctor Moreno, Seth M. Pollack, Scott M. Schuetze, Gary K. Schwartz, Sandra J. Strauss, William D. Tap, Fiona Thistlethwaite, Claudia Maria Valverde Morales, Michael J. Wagner, Breelyn A. Wilky, Cheryl McAlpine, Laura Hudson, Jean‐Marc Navenot, Tianjiao Wang, Jane P. F. Bai, Stavros Rafail, Ruoxi Wang, Amy Sun, Lilliam Fernandes, Erin Van Winkle, Erica Elefant, Colin Lunt, Elliot Norry, Dennis Williams, Swethajit Biswas, Brian Andrew Van Tine (2024). Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. , 403(10435), DOI: https://doi.org/10.1016/s0140-6736(24)00319-2.
Article33 days ago